secwatch.observer — SEC 8-K summary
======================================

Issuer:     ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
CIK:        0001688757
Form:       8-K
Filed at:   2023-02-27T23:59:59+00:00
Accession:  0001688757-23-000014
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Establishment Labs submits final PMA module for Motiva to FDA; Q4 revenue $43.8M, up 24% YoY; guides 2023 $200-210M
--------------------------------------------------------------------------------

- Submitted fourth and final module to U.S. FDA for premarket approval of Motiva Implants in the U.S.
- Q4 2022 revenue $43.8M, up 24.1% YoY; operating loss $13.6M vs $14.2M loss in prior year.
- 2023 revenue guidance $200M-$210M, representing 24%-30% growth over 2022.
- Cash balance $66.4M as of Dec 31, 2022; increased $12.9M from prior year.
- Mia Femtech commercialization on track; China approval expected H1 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1688757/000168875723000014/0001688757-23-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1688757/000168875723000014/esta-20230227.htm
  HTML page:      https://secwatch.observer/filing/0001688757-23-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer